Home/Filings/4/0001144204-18-003682
4//SEC Filing

MATHES RAINER 4

Accession 0001144204-18-003682

CIK 0001701040other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:16 PM ET

Size

5.7 KB

Accession

0001144204-18-003682

Insider Transaction Report

Form 4
Period: 2018-01-23
MATHES RAINER
President, Cision Insights
Transactions
  • Other

    Ordinary Shares

    2018-01-23+1,735,2691,735,269 total
Footnotes (2)
  • [F1]Doctor Rainer Mathes acquired these securities on January 23, 2018 in connection with the completion of the Share Purchase Agreement (the "SPA"), dated as of December 23, 2017, by and among Dr. Mathes and certain wholly owned subsidiaries of Cision Ltd. (the "Company") pursuant to which the Company indirectly acquired all of Dr. Mathes' interest in Prime Research Group. The SPA provides that up to EUR 2.5 million of deferred consideration amounts may be paid to Dr. Mathes in either cash or ordinary shares of the Company. Such election will be made at the sole discretion of Canyon UK Investments Ltd. ("Canyon") at the time such amounts (if any) become due. Canyon is a wholly owned subsidiary of the Company and a party to the SPA.
  • [F2]Pursuant to the Share Purchase Agreement, the price of the ordinary shares issued to Dr. Mathes was derived from the average market closing price of the Company's ordinary shares for the ten trading days preceding completion under the Share Purchase Agreement, or approximately $11.608 per share.

Issuer

CISION LTD.

CIK 0001701040

Entity typeother

Related Parties

1
  • filerCIK 0001729134

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:16 PM ET
Size
5.7 KB